0
2021
U.s. Pain Management Drugs Market

U.S. Pain Management Drugs Market

by Drug Class, (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drugs, Antidepressant Drugs, Opioids, Non-Narcotics, and Analgesics), Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute Appendicitis, and Other Indications), Pain Type (Chronic and Acute): Opportunity Analysis and Industry Forecast, 2020-2027
Update Available On-Demand

Report Code: A09451
Pages: 153
Jan 2021 | 2563 Views
Author(s) : Ravi Telugunta, Apoorva Srivastava , Onkar Sumant
Tables: 34
Charts: 57
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the U.s. Pain Management Drugs Market

Request Now !

U.S. Pain Management Drugs Market Overview:

The U.S. pain management drugs market size was valued at $31,499.07 million in 2019, and is projected to reach $39,356.45 million by 2027, registering a CAGR of 3.4%. 

The COVID-19 pandemic has stressed healthcare systems in U.S., so that many clinics, pain services are no longer open for public services because of safety. However, the telemedicine has become an appropriate and effective way to provide necessary medical services to patients with pain, which drives the market growth in near future.

Pain is an uncomfortable sensory and emotional sensation caused due to tissue injury or disease. It is caused due to injury and various diseases such as osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer, fibromyalgia and cancer. It can be defined as acute pain and chronic pain depending on duration.

US-Pain-Management-Drugs-Market-2020-2027

This pandemic has disrupted growth in many economies across various domains. The COVID-19 outbreak is anticipated to impact the growth of the pain management drugs market in the initial phase of the forecast period. The COVID-19 pandemic has stressed healthcare systems in the U.S., so that pain services in many clinics are no longer open for public services because of safety. Furthermore, the demand for pain management drugs is expected to rise during the latter half of the forecast period owing to telemedicine which has become an appropriate and effective way to offer necessary medical services to patients with chronic pain. Through telemedicine, physicians are able to provide guidance to patients for physical exercises at-home for pain relief.

Chronic pain is mainly caused due to aging conditions of bone and joints and nerve damage and injury. Pain is managed by a particular set of drugs to reduce the symptoms or treat pain. Pain process is complex and there are various drugs that provide relief by acting through a variety of physiological mechanism. Opioids are the most prescribed pain medication. These are narcotic pain medications containing natural and synthetic opiates. Opioids are usually used for acute pain, such as short-term pain after surgery. Morphine, Fentanyl, Oxycodone and Codeine are some of the opioids used for pain management.

As per the statistics by the National Cancer Institute, around 9.5 million individuals were reported to be suffering from cancer in the U.S. in 2019, and this number is expected to increase to 19 million in 2024. This is expected to increase the need of cancer pain drugs for therapeutic purposes, thus fueling the U.S. pain management drugs market growth. 

In recent times there is increased use of pain management drugs due to rise in aging population. Increasing prevalence of diseases such as cancer, diabetic neuropathy, osteoarthritis and chronic arthritis, increasing number of surgical procedures and increasing healthcare expenditure are some of the key factors driving the growth for the U.S. pain management drugs market. In addition, increasing healthcare awareness is also fuelling the growth of U.S. pain management drugs market. However, increase in generic completion, patent expiration of blockbuster drugs and availability of substitutes such as pain relief devices are some of the major factors restraining the growth for U.S. pain management drugs market. In addition, prescribing drug abuse would inhibit the growth of the market. 

Increasing R&D investment and outsourcing of pharmaceutical companies due to strong need for better treatment lead to market growth. In addition, novel molecule combination and drug delivery techniques would develop opportunity for the U.S. pain management drugs market. However, side effects of pain management drugs could lead a challenge for the pain management drugs market.

U.S. Pain Management Drugs Market
By Drug Class

Your browser does not support the canvas element.

Blood products holds the dominant position in 2019 and would continue to maintain the lead over the forecast period.

U.s. Pain Management Drugs Market Segmentation

The U.S. pain management drugs market is segmented on the basis of drug class, indication, and region. On the basis of drug class, the market is categorized into nonsteroidal anti-inflammatory drugs (NSAIDs), anesthetics, anticonvulsants, anti-migraine agents, antidepressants, opioids, and nonnarcotic analgesics. On the basis of indication, it is divided into arthritic pain, neuropathic pain, cancer pain, chronic back pain, postoperative pain, migraine, and fibromyalgia, bone fracture, muscle sprain, acute appendicitis and other indications.  On the basis of pain type, it is segmented into chronic pain and acute pain.

Segment review

On the basis of drug class, the opioids segment was the largest contributor to the market in 2019, owing to high efficiency of opioids to relieve pain in major chronic conditions. The anesthetics segment is anticipated to possess highest growth rate during the forecast period. 

U.S. Pain Management Drugs Market
By Indication

Your browser does not support the canvas element.

Neuropathic Pain segment is projected as one of the most lucrative segments.

By indication, the neuropathic pain segment accounted for a majority of the U.S. pain management drugs market share in 2019, and is expected to exhibit a prominent growth rate during the forecast period. In addition, increase in presence of large patient population is the major factor that increases demand for drugs for the segment. Cancer pain segment are expected to grow at the highest rate throughout the forecast period, owing to increase in number of surgeries and rise in prevalence of chronic diseases that lead to back pain.

The key players operating in the U.S. pain management drugs market include Novartis AG, Eli Lilly & Company, Abbott Laboratories, Purdue Pharma L.P., Boehringer Ingelheim, Pfizer, Inc., Mylan NV., Merck & Co. Inc., Johnson & Johnson, and GlaxoSmithKline Plc.

U.S. Pain Management Drugs Market
By Pain Type

2027
Chronic Pain 
Acute Pain

Chronic Pain holds the dominant position in 2019 and would continue to maintain the lead over the forecast period.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the U.S. pain management drugs market, with current trends and future estimations to elucidate the imminent investment pockets.
  • Quantitative analysis from 2019 to 2027 is expected to enable the stakeholders to capitalize on prevailing U.S. pain management drugs market opportunities.
  • The U.S. pain management drugs market size and estimations are based on a comprehensive analysis of key developments in the industry.
  • Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

U.S. Pain Management Drugs Market Report Highlights

Aspects Details
BY DRUG CLASS
  • NSAIDS
  • Anesthetics
  • Anticonvulsants
  • Antimigraine drug
  • Antidepressants
  • Opioids
  • Non-narcotic analgesics
By Indication
  • Arthritic Pain
  • Neuropathic Pain
  • Cancer Pain
  • Chronic Back Pain
  • Post-operative Pain
  • Migraine
  • Fibromyalgia
  • Bone fracture
  • Muscle sprain/strain
  • Acute appendicitis
  • Others
By Pain Type
  • Chronic pain
  • Acute pain
Key Market Players ABBOTT LABORATORIES, BOEHRINGER INGELHEIM INTERNATIONAL GMBH, ELI LILY AND COMPANY, GLAXOSMITHKLINE PLC (GSK), JOHNSON & JOHNSON, MERCK & CO., INC., MYLAN N.V., NOVARTIS INTERNATIONAL AG, PFIZER INC., PURDUE PHARMA L.P.
 

Loading Table Of Content...


 
 

The demand for pain management drugs has increased rapidly over the recent years. Pain can be caused due to various reasons such as chronic diseases, cancer, and surgeries. Thus, these segments are the largest contributors toward the market growth. Presence of large geriatric population base, rise in prevalence of cancer, and availability of pipeline drugs that pose to be promising treatment options for patients with chronic diseases contribute to the growth of the market. 

However, patent expiration of major best-seller drugs such as pregabalin and duloxetine by Pfizer and Eli Lilly & Co., respectively, and availability of alternative therapies such as acupuncture, massage, and medical devices hamper the market growth.

Employment of pain management drugs is the highest in the U.S., owing to increase in adoption of these drugs, high prevalence of chronic diseases, and increase in disposable income of customers in the U.S. In addition, presence of a large geriatric population and favorable regulatory & healthcare reforms such as the U.S. Patient Protection and Affordable Care Act of 2010 supplement the market growth. However, drug exploitation, patent expiration of prescription pain medication drugs, and availability of substitutes such as pain relief devices restrain the market growth. 
 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. A wide range of drugs are used to manage pain resulting from inflammation in response to tissue damage, chemical agents/pathogens (nociceptive pain) or nerve damage (neuropathic pain).

A. Pain is a general term that describes uncomfortable sensations in the body. It stems from activation of the nervous system. Pain can range from annoying to debilitating, and it can feel like a sharp stabbing or a dull ache. Pain can also be described as throbbing, stinging, sore, and pinching.

A. The major factor that fuels the growth of the global U.S. Pain Management Drugs Market includes rise in incidences of chronic diseases, favorable regulatory scenario, and increase in geriatric population drive the growth of the U.S. pain management drugs market.However, Availability of alternative therapies and drug exploitation are expected to hamper the market growth.

A. The total market value of U.S. Pain Management Drugs Market is $31,499.07 million in 2019.

A. The forcast period for U.S. Pain Management Drugs Market is 2020 to 2027

A. The market value of U.S. Pain Management Drugs Market in 2027 is $39,356.45 million.

A. The base year is 2019 in U.S. Pain Management Drugs Market

A. Top companies such as Pfizer, Purdue Pharma, Eli Lilly and others held a high market position in 2019. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. In drug class segment Opioids is the most influencing segment. This is attributed to surge in prevalence of hematological diseases and rise in accidents.By application, the global U.S. Pain Management Drugs Market is bifurcated into therapeutic and research.

A. Increase in R&D activities for development of novel drugs with fewer side-effects and regulatory authorities designate certain rapid-track production drugs to speed up regulatory approvals and market entry processes. This is due to improvement in health awareness, development in healthcare infrastructure, and rise in number of hospitals equipped with advanced medical facilities.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Free Sample

OR

Purchase Full Report of
U.s. Pain Management Drugs Market

Start reading instantly.
This Report and over 18,833+ more Reports, Available with Avenue Library. T&C*.

  • Data Pack
  • $2,038
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jan 2022 - Jan 2023)
  • Single User
  • $2,850
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jan 2022 - Jan 2023)
  • Five Users
  • $3,423
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jan 2022 - Jan 2023)
  • Enterprise
    License/PDF

  • $5,774
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jan 2022 - Jan 2023)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers